Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending:
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2005
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
11229 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 36, [16] S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023591398 | ||
| 003 | DE-604 | ||
| 005 | 20100226 | ||
| 007 | t | ||
| 008 | 051020s2005 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)59007879 | ||
| 035 | |a (DE-599)BVBBV023591398 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HB1 | |
| 100 | 1 | |a Golec, Joseph |e Verfasser |0 (DE-588)13049738X |4 aut | |
| 245 | 1 | 0 | |a Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending |c Joseph Golec ; Shantaram Hedge ; John Vernon |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2005 | |
| 300 | |a 36, [16] S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11229 | |
| 610 | 2 | 4 | |a United States. |t Health Security Act |x Economic aspects |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Ökonometrisches Modell | |
| 650 | 4 | |a Drug Industry |x economics | |
| 650 | 4 | |a Drugs |x Prices |x Law and legislation |x Economic aspects |z United States | |
| 650 | 4 | |a Drugs |x Research |x Economic aspects |z United States | |
| 650 | 4 | |a Legislation, Medical |x economics | |
| 650 | 4 | |a Models, Economic | |
| 650 | 4 | |a Pharmaceutical industry |z United States |x Econometric models | |
| 650 | 4 | |a Research |x economics | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Hedge, Shantaram |e Verfasser |0 (DE-588)130497460 |4 aut | |
| 700 | 1 | |a Vernon, John A. |e Verfasser |0 (DE-588)130457043 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11229 |w (DE-604)BV002801238 |9 11229 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w11229.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016906728 | ||
Datensatz im Suchindex
| _version_ | 1804138248702787584 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Golec, Joseph Hedge, Shantaram Vernon, John A. |
| author_GND | (DE-588)13049738X (DE-588)130497460 (DE-588)130457043 |
| author_facet | Golec, Joseph Hedge, Shantaram Vernon, John A. |
| author_role | aut aut aut |
| author_sort | Golec, Joseph |
| author_variant | j g jg s h sh j a v ja jav |
| building | Verbundindex |
| bvnumber | BV023591398 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)59007879 (DE-599)BVBBV023591398 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01884nam a2200469zcb4500</leader><controlfield tag="001">BV023591398</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100226 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051020s2005 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)59007879</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591398</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Golec, Joseph</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)13049738X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending</subfield><subfield code="c">Joseph Golec ; Shantaram Hedge ; John Vernon</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">36, [16] S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11229</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States.</subfield><subfield code="t">Health Security Act</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ökonometrisches Modell</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="x">Law and legislation</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Medical</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Models, Economic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield><subfield code="x">economics</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hedge, Shantaram</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130497460</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vernon, John A.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130457043</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11229</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">11229</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w11229.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016906728</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023591398 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:28Z |
| indexdate | 2024-07-09T21:25:10Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016906728 |
| oclc_num | 59007879 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 36, [16] S. graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Golec, Joseph Verfasser (DE-588)13049738X aut Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending Joseph Golec ; Shantaram Hedge ; John Vernon Cambridge, Mass. National Bureau of Economic Research 2005 36, [16] S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11229 United States. Health Security Act Economic aspects Recht Ökonometrisches Modell Drug Industry economics Drugs Prices Law and legislation Economic aspects United States Drugs Research Economic aspects United States Legislation, Medical economics Models, Economic Pharmaceutical industry United States Econometric models Research economics USA Hedge, Shantaram Verfasser (DE-588)130497460 aut Vernon, John A. Verfasser (DE-588)130457043 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11229 (DE-604)BV002801238 11229 http://papers.nber.org/papers/w11229.pdf kostenfrei Volltext |
| spellingShingle | Golec, Joseph Hedge, Shantaram Vernon, John A. Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series United States. Health Security Act Economic aspects Recht Ökonometrisches Modell Drug Industry economics Drugs Prices Law and legislation Economic aspects United States Drugs Research Economic aspects United States Legislation, Medical economics Models, Economic Pharmaceutical industry United States Econometric models Research economics |
| title | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending |
| title_auth | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending |
| title_exact_search | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending |
| title_exact_search_txtP | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending |
| title_full | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending Joseph Golec ; Shantaram Hedge ; John Vernon |
| title_fullStr | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending Joseph Golec ; Shantaram Hedge ; John Vernon |
| title_full_unstemmed | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending Joseph Golec ; Shantaram Hedge ; John Vernon |
| title_short | Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending |
| title_sort | pharmaceutical stock price reactions to price constraint threats and firm level r d spending |
| topic | United States. Health Security Act Economic aspects Recht Ökonometrisches Modell Drug Industry economics Drugs Prices Law and legislation Economic aspects United States Drugs Research Economic aspects United States Legislation, Medical economics Models, Economic Pharmaceutical industry United States Econometric models Research economics |
| topic_facet | United States. Health Security Act Economic aspects Recht Ökonometrisches Modell Drug Industry economics Drugs Prices Law and legislation Economic aspects United States Drugs Research Economic aspects United States Legislation, Medical economics Models, Economic Pharmaceutical industry United States Econometric models Research economics USA |
| url | http://papers.nber.org/papers/w11229.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT golecjoseph pharmaceuticalstockpricereactionstopriceconstraintthreatsandfirmlevelrdspending AT hedgeshantaram pharmaceuticalstockpricereactionstopriceconstraintthreatsandfirmlevelrdspending AT vernonjohna pharmaceuticalstockpricereactionstopriceconstraintthreatsandfirmlevelrdspending |